Results 171 to 180 of about 15,493 (219)

Features of Swallowing Function in Sporadic Inclusion Body Myositis: Preliminary Evidence Using Well-Tested Assessment Frameworks. [PDF]

Am J Speech Lang Pathol
Ambrocio KR, Aggarwal R, Lacomis D, Zhang X, Garand KLF.   +4 more
europepmc   +1 more source

Anesthesia Spearheading Perioperative Safety Efforts in a Patient with Inclusion Body Myositis: A Case Report. [PDF]

Acta Med Philipp
Aspi MTB, Arancon AKCV.
europepmc   +1 more source

Differentiating Inclusion Body Myositis From Amyotrophic Lateral Sclerosis Based on the Features of Dysphagia: Insights From a Patient With Rapidly Progressive Dysphagia. [PDF]

J Clin Neurol
Je Y, Park YE, Shin YB.
europepmc   +1 more source

Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles. [PDF]

PLoS One
Suzuki N, Kanzaki M, Koide M, Izumi R, Fujita R, Takahashi T, Ogawa K, Yabe Y, Tsuchiya M, Suzuki M, Harada R, Ohno A, Ono H, Nakamura N, Ikeda K, Warita H, Osana S, Oikawa Y, Toyohara T, Abe T, Rui M, Ebihara S, Nagatomi R, Hagiwara Y, Aoki M.   +24 more
europepmc   +1 more source

Compound muscle action potential of whole-forearm flexors: A clinical biomarker for inclusion body myositis. [PDF]

Clin Neurophysiol Pract
Mano T, Iguchi N, Iwasa N, Yamada N, Sugie K.   +4 more
europepmc   +1 more source

Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy. [PDF]

J Cachexia Sarcopenia Muscle
Reyngoudt H, Baudin PY, Caldas de Almeida Araújo E, Bachasson D, Boisserie JM, Mariampillai K, Annoussamy M, Allenbach Y, Hogrel JY, Carlier PG, Marty B, Benveniste O.   +11 more
europepmc   +1 more source

Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging. [PDF]

Int J Mol Sci
Guglielmi V, Cheli M, Tonin P, Vattemi G.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Inclusion body myositis

Current Opinion in Rheumatology, 2014
To examine new developments in sporadic inclusion body myositis (IBM), including updated clinical and prognostic factors, novel autoantibody associations, unique histopathologic findings, proposed new clinical diagnostic criteria, and novel therapeutic agents.IBM is a slowly progressive disease, leading to wheelchair use, on average, 12-20 years after ...
Arash H, Lahouti, Anthony A, Amato, Lisa, Christopher-Stine   +2 more
openaire   +4 more sources

Inclusion body myositis

Current Opinion in Neurology, 1999
Sporadic inclusion body myositis is a severely disabling muscle disease that mainly affects elderly individuals. The typical distribution of muscle weakness, poor response to immunosuppressive treatment, pathological accumulation of various proteins in vacuolated muscle fibres, inflammatory reaction and mitochondrial changes have all been subjects of ...
A, Oldfors, C, Lindberg
openaire   +4 more sources

Inclusion Body Myositis

Continuum, 2022
This article highlights the clinical and diagnostic features of inclusion body myositis (IBM) and provides recent insights into the pathomechanisms and therapeutic strategies of the disease.IBM is an often-misdiagnosed myopathy subtype. Due to the insidious onset and slow progression of muscle weakness, it can often be dismissed as a sign of aging as ...
openaire   +2 more sources